| 0.33 -0.04 (-12.12%) | 10-14 13:41 | |||||||||||||
|
|
| Short term |  |
|||
| Mid term |  |
|||
| Targets | 6-month : | 0.4 | 1-year : | 0.47 |
| Resists | First : | 0.34 | Second : | 0.4 |
| Pivot price | 0.32  |
|||
| Supports | First : | 0.28 | Second : | 0.23 |
| MAs | MA(5) : | 0.33  |
MA(20) : | 0.31 |
| MA(100) : | 0.35 |
MA(250) : | 0.38 |
|
| MACD | MACD : | 0 |
Signal : | 0 |
| %K %D | K(14,3) : | 75 | D(3) : | 76.3 |
| RSI | RSI(14): 53.3 | |||
| 52-week | High : | 0.77 | Low : | 0.2 |
Price has closed below its short-term moving average. Short-term moving average is currently above mid-term; and below long-term moving average. From the relationship between price and moving averages: This stock is NEUTRAL in short-term; and NEUTRAL in mid-long term.[ CYAN ] has closed below upper band by 45.2%. Bollinger Bands are 35.2% narrower than normal. The current width of the bands does not suggest anything about the future direction or movement of prices.
| If tomorrow: | Open lower | Open higher |
| High: | 0.33 - 0.33 | 0.33 - 0.33 |
| Low: | 0.27 - 0.27 | 0.27 - 0.27 |
| Close: | 0.33 - 0.33 | 0.33 - 0.33 |
Cyanotech Corporation engages in the cultivation, production, and sale of natural products derived from microalgae worldwide. The company's products include BioAstin Hawaiian Astaxanthin, a dietary antioxidant to enhance skin, and to support eye, joint and immune health, as well as used as a human dietary supplement and dietary ingredient; and Hawaiian Spirulina Pacifica, a nutrient-rich dietary supplement, which is used for extra energy, strengthened immune system, cardiovascular benefits, and as a source of antioxidant carotenoids. It also provides contract extraction services. The company sells its products through distributors, retailers, and online channels; direct to consumers; and in bulk form to manufacturers, formulators, and distributors in the health foods, nutraceuticals, and dietary supplement markets. Cyanotech Corporation was incorporated in 1983 and is headquartered in Kailua-Kona, Hawaii.
Fri, 08 Aug 2025
Earnings call transcript: Cyanotech sees improved gross profit in Q1 2025 - Investing.com
Wed, 06 Aug 2025
Cyanotech Reports Financial Results for the First Quarter of Fiscal 2026 - Business Wire
Fri, 20 Jun 2025
Cyanotech Reports Financial Results for the Fourth Quarter and Fiscal Year 2025 - Business Wire
Thu, 29 Feb 2024
13 Highest Paying Countries for Marine Biologists - Yahoo Finance
Tue, 13 Feb 2024
Cyanotech Corporation (NASDAQ:CYAN) Q3 2024 Earnings Call Transcript - Yahoo Finance
Sun, 08 Oct 2023
Cyanotech sales up 19% - New Hope Network
| Price to Book Value: P/BV, a ratio used to compare book value to its current market price, to gauge whether a stock is valued properly. |
Outperform |
| Price to Earnings: PE, the ratio for valuing a company that measures its current share price relative to its earnings per share (EPS). |
Underperform |
| Discounted cash flow: DCF, a valuation method used to estimate the value of an investment based on its expected future cash flows. |
Outperform |
| Return on Assets: ROA, indicates how profitable a company is in relation to its total assets, how efficiently uses assets to generate a profit. |
Underperform |
| Return on Equity: ROE, a measure of financial performance calculated by dividing net income by equity. a gauge of profitability and efficiency. |
Underperform |
| Debt to Equity: evaluate financial leverage, reflects the ability of equity to cover outstanding debts in the event of a business downturn. |
Underperform |
|
Exchange:
OTC
|
|
|
Sector:
Consumer Defensive
|
|
|
Industry:
Packaged Foods
|
|
| Shares Out | 7 (M) |
| Shares Float | 5 (M) |
| Held by Insiders | 38 (%) |
| Held by Institutions | 0 (%) |
| Shares Short | 0 (K) |
| Shares Short P.Month | 4 (K) |
| EPS | -0.76 |
| EPS Est Next Qtrly | 0 |
| EPS Est This Year | 0 |
| EPS Est Next Year | 0 |
| Book Value (p.s.) | 1.52 |
| Profit Margin | -21.5 % |
| Operating Margin | -17.7 % |
| Return on Assets (ttm) | -9.9 % |
| Return on Equity (ttm) | -39.7 % |
| Qtrly Rev. Growth | 14.6 % |
| Gross Profit (p.s.) | 0 |
| Sales Per Share | 3.36 |
| EBITDA (p.s.) | -0.38 |
| Qtrly Earnings Growth | 0 % |
| Operating Cash Flow | 0 (M) |
| Levered Free Cash Flow | 3 (M) |
| PE Ratio | -0.44 |
| PEG Ratio | 0 |
| Price to Book value | 0.21 |
| Price to Sales | 0.09 |
| Price to Cash Flow | 6.08 |
| Dividend | 0 |
| Forward Dividend | 0 |
| Dividend Yield | 0% |
| Dividend Pay Date | Invalid DateTime. |
| Ex-Dividend Date | Invalid DateTime. |
|
|
|
|
|
|
|
|
|